PMS38 Cost-Effectiveness of Tapentadol for Severe Chronic Non-Cancer Pain in Belgium

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1393
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PSY32 Modeling Cost-Effectiveness of Drug Treatments for Severe Chronic Non-Cancer Pain in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

PSY5 a Systematic Review of Tapentadol in Chronic Moderate to Severe Pain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Tapentadol Extended-Release for Treatment of Chronic Pain: A Review

Journal of Pain Research
AnesthesiologyPain Medicine
2011English

Opioids for Chronic Non-Cancer Pain

British Medical Journal
Medicine
2013English

Opioids for Chronic Non-Cancer Pain

2019English

Tapentadol in the Management of Pain in Cancer Patients

Journal of Cancer Science and Clinical Therapeutics
2019English

Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly—A Subgroup Analysis of Routine Clinical Practice Data

Pain Research and Management
NeurologyAnesthesiologyPain Medicine
2020English

Prediction of Response to Tapentadol in Chronic Low Back Pain

European Journal of Pain
MedicineAnesthesiologyPain Medicine
2016English

Effectiveness of Massage Therapy for Chronic, Non-Malignant Pain: A Review

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy